lrinotecan Market Report Opportunities, and Forecast By 2033
(0 User reviews)
180
96
Abstract
According to the Market Statsville Group (MSG), the Global lrinotecan Market size is expected to grow at a CAGR of 6.1% from 2023 to 2033.
Camptosar, also known as irinotecan, is a drug used in the treatment of cancers of the colon and the lungs. It can be used alone or in combination with fluorouracil to treat colon cancer. It is used with cisplatin to treat small cell lung cancer. Irinotecan is injected intravenously (into a vein) by a doctor or nurse during a 90-minute period. Irinotecan works as a topoisomerase I inhibitor. It operates by decreasing the action of topoisomerase I, an enzyme involved in DNA replication and repair. Irinotecan prevents the unwinding of DNA strands, resulting in DNA damage and eventually reducing the proliferation of cancer cells by blocking this enzyme.
According to the Market Statsville Group (MSG), the Global lrinotecan Market size is expected to grow at a CAGR of 6.1% from 2023 to 2033.
Camptosar, also known as irinotecan, is a drug used in the treatment of cancers of the colon and the lungs. It can be used alone or in combination with fluorouracil to treat colon cancer. It is used with cisplatin to treat small cell lung cancer. Irinotecan is injected intravenously (into a vein) by a doctor or nurse during a 90-minute period. Irinotecan works as a topoisomerase I inhibitor. It operates by decreasing the action of topoisomerase I, an enzyme involved in DNA replication and repair. Irinotecan prevents the unwinding of DNA strands, resulting in DNA damage and eventually reducing the proliferation of cancer cells by blocking this enzyme.
There are no reviews for this PDF.
There are no comments for this PDF.
You must log in to post a comment.
Log in
